Skip to main content
SpringerLink
Log in

Aflibercept/brolucizumab/ranibizumab

Macular hole, retinal artery occlusion and lack of efficacy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bilgic A, et al. Real-world experience with brolucizumab in wet age-related macular degeneration: The reba study. Journal of Clinical Medicine 10: 2758, No. 13, Jul 2021. Available from: URL: https://www.mdpi.com/2077-0383/10/13/2758/pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/brolucizumab/ranibizumab. Reactions Weekly 1879, 20 (2021). https://doi.org/10.1007/s40278-021-04504-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-04504-0

Search

Navigation